---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018441"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2025-10-17T23:59:59+00:00"
generated_at: "2026-05-17T03:22:37.706824+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# SRx Health receives NYSE American deficiency notice for stockholders' equity below $4M

## Summary
- Received NYSE American notice on Oct 14, 2025 for non-compliance with Section 1003(a)(ii) due to stockholders' equity below $4M and net losses.
- Company must submit compliance plan by Nov 13, 2025 and cure deficiency by July 14, 2026.
- No immediate delisting; common stock continues trading on NYSE American under symbol SRXH.
- Company is actively developing measures to regain compliance within the cure period.

## SEC filing metadata
- accession: 0001493152-25-018441
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2025-10-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315225018441/0001493152-25-018441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315225018441/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018441
- JSON: https://secwatch.observer/filing/0001493152-25-018441.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018441.txt

## Key facts
- Listing & Compliance Notices
  SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1009).
  - Exchange: nyse american
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 1003(a)(ii), 1009
  source text: October 14, 2025, SRx Health Solutions, Inc, a Delaware corporation. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (“Section 1003(a)(ii)”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.. T
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315225018441/0001493152-25-018441-index.htm
- Listing & Compliance Notices
  SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii)).
  - Exchange: nyse american
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 1003(a)(ii)
  source text: October 14, 2025, SRx Health Solutions, Inc, a Delaware corporation. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (“Section 1003(a)(ii)”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.. T
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315225018441/0001493152-25-018441-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.